Insights
CVS Health Corporation Q1 2026 Results
The most surprising finding in Elevance Health’s Q1 2026 report is not the 16% adjusted EPS beat—it is the hidden anatomy of that beat. Of the $12.58 adjusted EPS.
September 29, 2026
Analysis, playbooks, and research for government-sponsored health plans navigating a faster, more competitive market.
The most surprising finding in Elevance Health’s Q1 2026 report is not the 16% adjusted EPS beat—it is the hidden anatomy of that beat. Of the $12.58 adjusted EPS.
The 8 largest non-SNP payers, the fastest-growing D-SNP and C-SNP plans, the key AEP cost versus benefit trade-offs driving member choice, and what these trends mean for your bids, Star Ratings, and provider network strategy.
The 8 largest non-SNP payers, the D-SNP/C-SNP plans moving fastest, and the AEP cost & benefit trade-offs behind them — plus what it means for your bid, your Stars, and your network.
MA strategy has converged around margin over membership, UnitedHealth and CVS are both deliberately trading enrollment for margin, while Humana and Alignment are the visible outliers still guiding double-digit MA growth.
Alignment Healthcare’s Q2 2026 earnings beat guidance across the board, yet shares fell as second-half margin cadence weakens.
Alignment Healthcare’s Q2 2026 earnings beat guidance across the board, yet shares fell as second-half margin cadence weakens.
The healthcare payer industry is changing rapidly—and our resources help you stay on top of it all. Sign up to get new insights, success stories, and more, sent right to your inbox.
Thanks for subscribing — keep an eye on your inbox for our next resource.